Adrenal Castleman's disease [3]

Annals of Hematology

Volumn 86, Issue 1, 2007, Pages 63-65

  Müssig, Karsten ^a   Horger, Marius ^a   Wehrmann, Manfred ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 131; AMLODIPINE; FLUORODEOXYGLUCOSE F 18; INTERLEUKIN 6; IOPROMIDE; IRBESARTAN; MOXONIDINE; SPIRONOLACTONE; URAPIDIL;

ADRENAL DISEASE; ADULT; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONVALESCENCE; DISEASE SEVERITY; ECHOGRAPHY; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HYPERTENSION; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; LAPAROTOMY; LETTER; LYMPHOCYTE; MALE; PATIENT REFERRAL; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADRENAL GLAND DISEASES; GIANT LYMPH NODE HYPERPLASIA; HUMANS; MALE; MIDDLE AGED;

EID: 33846429566     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-006-0200-7     Document Type: Letter

References (12)

1. Keller AR, Hochholzer L, Castleman B (1972) Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer 29:670-683
2. Bowne WB, Lewis JJ, Filippa DA, Niesvizky R, Brooks AD, Burt ME, Brennan MF (1999) The management of unicentric and multicentric Castleman's disease: A report of 16 cases and a review of the literature. Cancer 85:706-717
3. Debatin JF, Spritzer CE, Dunnick NR (1991) Castleman disease of the adrenal gland: MR imaging features. AJR Am J Roentgenol 157:781-783
4. Gupta NP, Ansari MS, Chopra P, Dinda AK (2002) Castleman's disease masquerading as an adrenal tumor. J Urol 168:2524
5. Chen JH, Yu CY, Pai CY, Chan DC, Chen CJ, Yu JC, Liu YC (2005) Castleman's disease in the left upper retroperitoneal space mimicking an adrenal neoplasm: Report of a case and literature review. Jpn J Clin Oncol 35:353-356
6. Leger-Ravet MB, Peuchmaur M, Devergne O, Audouin J, Raphael M, Van Damme J, Galanaud P, Diebold J, Emilie D (1991) Interleukin-6 gene expression in Castleman's disease. Blood 78:2923-2930
7. Papanicolaou DA, Wilder RL, Manolagas SC, Chrousos GP (1998) The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med 128:127-137
8. Mastorakos G, Chrousos GP, Weber JS (1993) Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans. J Clin Endocrinol Metab 77:1690-1694
9. Franchimont N, Wertz S, Malaise M (2005) Interleukin-6: An osteotropic factor influencing bone formation? Bone 37:601-606
10. Erices A, Conget P, Rojas C, Minguell JJ (2002) Gp130 activation by soluble interleukin-6 receptor/interleukin-6 enhances osteoblastic differentiation of human bone marrow-derived mesenchymal stem cells. Exp Cell Res 280:24-32
11. Taguchi Y, Yamamoto M, Yamate T, Lin SC, Mocharla H, DeTogni P, Nakayama N, Boyce BF, Abe E, Manolagas SC (1998) Interleukin-6-type cytokines stimulate mesenchymal progenitor differentiation toward the osteoblastic lineage. Proc Assoc Am Physicians 110:559-574
12. Müssig K, Gallwitz B, Machicao F, Horger M, Häring HU, Kaiserling E (2006) Paraadrenal Castleman disease presenting with adrenal hyperandrogenism. J Endocrinol Investig 29:172-176